Hamlins advises on AIM fundraising for Tyratech, Inc.

The Hamlins Corporate team advised Allenby Capital on a £3.16 million placing and subscription for AIM-quoted Tyratech, Inc. the life sciences company which focuses on nature-derived insect and parasite control products. Reed Smith acted for Tyratech.